A new study focusing on the common CA-125 blood test found that some patients were 23 percent less likely to show elevated ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
A recent study found that women using birth control pills after age 45 had a 43% lower risk of developing ovarian cancer. The ...
In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences ...
Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...
An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...
Researchers found that Black and Native American patients were 23% less likely to have high levels of CA-125 when diagnosed ...
The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their treatment ...
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to ...